ArticleWorld journal of clinical cases2021
S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report.
Xin Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it